Private company
Decibel Therapeutics, Inc.
American pharmaceutical preparations company, incorporated in Delaware.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Cash | $27.7M3 | $36.5M4 | $34.6M4 | ||
| Current assets | $57.8M3 | $164.2M4 | $108.0M4 | ||
| Total assets | $67.3M3 | $184.5M4 | $123.4M4 | ||
| Current liabilities | $19.4M3 | $20.5M4 | $22.4M4 | ||
| Total liabilities | $29.0M3 | $42.8M4 | $41.6M4 | ||
| Shareholders’ equity | -$121.8M3 | -$54.8M4 | $141.7M4 | $81.8M4 | |
| Shares outstanding | 521.1K shares3 | 25.0M shares4 | 25.0M shares4 | 25.0M shares4 |
Leadership
Who has led Decibel Therapeutics, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerLaurence Reid Sep 17, 2021 to Sep 17, 20217
- PresidentLaurence Reid Sep 17, 2021 to Sep 17, 20217
- Chief financial officerElisabeth Leiderman Feb 28, 2022 to Feb 28, 20228
Board members and other officers (16)
- OfficerJames B. Murphy Oct 12, 2022 to Oct 12, 20229
- OfficerAnna Trask Feb 11, 2021 to Sep 25, 202310
- OfficerElisabeth Leiderman Feb 11, 2021 to Feb 11, 202111
- OfficerLaurence Reid Feb 11, 2021 to Sep 25, 202312
- Board memberMatthew C. Kapusta Mar 21, 2023 to Sep 25, 202313
- Board memberKevin F. McLaughlin Oct 12, 2022 to Sep 25, 202314
- Board memberChristine Poon Feb 11, 2021 to Feb 16, 202115
- Board memberLaurence Reid Feb 11, 2021 to Sep 25, 202312
- Board memberMatthew Foy Feb 11, 2021 to Feb 19, 202116
- Board memberNeil Exter Feb 11, 2021 to Jun 21, 202217
- Board memberPeter A. Thompson Feb 11, 2021 to Jun 21, 202218
- Board memberPlc Glaxosmithkline Feb 11, 2021 to Feb 19, 202119
- Board memberWilliam H. Carson Jun 3, 2021 to Sep 25, 202320
- Board memberAlison Cecily Finger Dec 6, 2021 to Sep 25, 202321
- Board memberSara Nochur Dec 6, 2021 to Sep 25, 202322
- General counselCynthia Wong Aug 18, 2021 to Aug 18, 202123
Timeline
- Sep 17, 2021New chief executive Laurence Reid becomes CEO7
Filings
91 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 16 major events, 38 insider forms, 5 large holders, 24 other. The latest 20:
- Feb 14, 2024SC 13G/A EDGAR
- Oct 10, 202315-12G EDGAR
- Oct 6, 2023EFFECT EDGAR
- Sep 25, 2023S-8 POS EDGAR
- Sep 25, 2023S-8 POS EDGAR
- Sep 25, 2023S-8 POS EDGAR
- Sep 25, 2023POS AM EDGAR
- Sep 25, 20238-K EDGAR
- Sep 25, 2023SC 14D9/A EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 25, 20234 FORM 4 SUBMISSION EDGAR
- Sep 12, 2023SC 14D9/A EDGAR
- Sep 8, 2023SC 14D9/A EDGAR
- Aug 25, 2023SC 14D9 EDGAR
The 91 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 5 such filings since October 2021:
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARJames B. Murphy, Officer
- 10SEC EDGARAnna Trask, Officer
- 11SEC EDGARElisabeth Leiderman, Officer
- 12SEC EDGARLaurence Reid, Officer
- 13SEC EDGARMatthew C. Kapusta, Board member
- 14SEC EDGARKevin F. McLaughlin, Board member
- 15SEC EDGARChristine Poon, Board member
- 16SEC EDGARMatthew Foy, Board member
- 17SEC EDGARNeil Exter, Board member
- 18SEC EDGARPeter A. Thompson, Board member
- 19SEC EDGARPlc Glaxosmithkline, Board member
- 20SEC EDGARWilliam H. Carson, Board member
- 21SEC EDGARAlison Cecily Finger, Board member
- 22SEC EDGARSara Nochur, Board member
- 23SEC EDGARCynthia Wong, General counsel